WS03.04 Survival of people with cystic fibrosis: complete overview in France and first evaluation of the impact of modulators

Survival of people with CF has greatly improved over past decades and will still progress with the advent of modulators. Registries have been instrumental in demonstrating this improved survival but not all present the same metrics. This study analyzed the survival of French patients using all recent methods and assessed the first impact of elexacaftor/tezacaftor/ivacaftor (ETI).